Relay Therapeutics Inc
NASDAQ:RLAY 12:27:23 AM EDT
| Market Cap (Intraday) | 788.42M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.32 |
| 50-Day MA | $8.35 |
| 200-Day MA | $9.30 |
Relay Therapeutics Inc Stock, NASDAQ:RLAY
399 Binney Street, 2nd floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.370.8837
Number of Employees: 323
Description
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.